Pan-European monitoring of susceptibility to human-use antimicrobial agents in enteric bacteria isolated from healthy food-producing animals

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 3, 2012, Pages 638-651

  De jong, Anno ^a,b   Thomas, Valérie ^a,c   Simjee, Shabbir ^a,d   Godinho, Kevin ^a,e   Schiessl, Brigitte ^a,f   Klein, Ulrich ^a,f   Butty, Pascal ^a,g   Vallé, Michel ^a,h   Marion, Hervé ⁱ   Shryock, Thomas R ^d  

^a EASSA Study Group   (Belgium)

^b BAYER PHARMA AG   (Germany)

^c INTERVET INTERNATIONAL BV   (Netherlands)

^d ELANCO ANIMAL HEALTH   (United States)

^e ZOETIS   (United States)

^f NOVARTIS PHARMA AG   (Switzerland)

^g CEVA SANTÉ ANIMALE   (France)

^h Vetoquinol SA   (France)

ⁱ European Animal Health Study Centre (CEESA)   (Belgium)

Author keywords

Antimicrobial resistance; Campylobacter; E. coli; Enterococcus; Salmonella; Surveillance

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFEPIME; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; NALIDIXIC ACID; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CATTLE; CHICKEN; CONTROLLED STUDY; DENMARK; DRUG SURVEILLANCE PROGRAM; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; EUROPEAN UNION; FRANCE; GERMANY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; SALMONELLA; SALMONELLA TYPHIMURIUM; SWINE; UNITED KINGDOM;

ABATTOIRS; ANIMALS; ANTI-INFECTIVE AGENTS; CATTLE; CHICKENS; ENTEROBACTERIACEAE; EUROPEAN UNION; INTESTINES; MICROBIAL SENSITIVITY TESTS; SWINE;

EID: 84856970549     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr539     Document Type: Article

References (44)

1. DANMAP. Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Foods and Humans in Denmark. 2009. http://www.danmap.org/ (9 March 2011, date last accessed).
2. FARM. French Antimicrobial Resistance Monitoring Program in Bacteria of Animal Origin. 2007-08. http://www.anses.fr/Documents/SANT-Ra-FARM.pdf (30 January 2011, date last accessed).
3. MARAN. Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2006/2007. 2007. http://www.cidc-lelystad.nl (9 September 2010, date last accessed).
4. NORM/NORM-VET. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. 2008. http://www.vetinst.no (3 November 2011, date last accessed).
5. SVARM. Swedish Veterinary Antimicrobial Resistance Monitoring. 2010. The National Veterinary Institute (SVA), Uppsala, Sweden. http://www.sva.se (14 April 2011, date last accessed).
6. VAV. Veterinary Monitoring of Antimicrobial Resistance in Spain. Twelfth Report. 2005. http://www.vigilanciasanitaria.es/data/VAV2005.pdf (14 November 2011, date last accessed).
7. Franklin A, Acar J, Anthony F et al. Antimicrobial resistance: harmonisation of national antimicrobial resistance monitoring and surveillance programmes in animals and in animal-derived food. Rev Sci Tech 2001; 20: 859-70.
8. White DG, Acar J, Anthony F et al. Antimicrobial resistance: standardisation and harmonisation of laboratory methodologies for the detection and quantification of antimicrobial resistance. Rev Sci Tech 2001; 20: 849-58.
9. Schwarz S, Simjee S, Woodford N et al. Assessing the antimicrobial susceptibility of bacteria obtained from animals. Vet Microbiol 2010; [141:] 1-4.
10. Giske CG, Cornaglia G, on behalf of EDGARS. Supranational surveillance of antimicrobial resistance: the legacy of the last decade and proposals for the future. Drug Resist Updat 2010; 13: 93-8.
11. Silley P, de Jong A, Simjee S et al. Harmonisation of resistance monitoring programmes in veterinary medicine: an urgent need in the EU? Int J Antimicrob Agents 2011; 37: 504-12.
12. Aarestrup FM, McDermott PF, Kahlmeter G. Antimicrobial susceptibility testing clinical breakpoints and epidemiological cut-off values. Newsletter CRL-AR-No. 2 November 2007.
13. Report from the task force on zoonoses data collection including guidance for harmonized monitoring and reporting of antimicrobial resistance in commensal Escherichia coli and Enterococcus spp. from food animals. EFSA J 2008; 141: 1-44.
14. Report of the task force on zoonoses data collection including a proposal for a harmonized monitoring scheme of antimicrobial resistance in Salmonella in fowl (Gallus gallus), turkeys, and pigs and Campylobacter jejuni and C. coli in broilers. EFSA J 2007; 96: 1-46.
15. EUCAST. www.srga.org/EUCASTwt/eucast.htm (11 July 2011, date last accessed).
16. Bywater R, Deluyker H, Deroover E et al. A European survey of antimicrobial susceptibility among zoonotic and commensal bacteria isolated from food-producing animals. J Antimicrob Chemother 2004; 54: 744-54.
17. de Jong A, Bywater R, Butty P et al. A pan-European survey of antimicrobial susceptibility towards human-use antimicrobial drugs among zoonotic and commensal enteric bacteria isolated from healthy food-producing animals. J Antimicrob Chemother 2009; 63: 733-44.
18. Bywater R, McConville M, Phillips I et al. The susceptibility to growth-promoting antibiotics of Enterococcus faecium isolates from pigs and chickens in Europe. J Antimicrob Chemother 2005; 56: 538-43.
19. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals-Third Edition: Approved Standard M31-A3. CLSI, Wayne, PA, USA, 2008.
20. Clinical and Laboratory Standards Institute. Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria-Second Edition: Approved Guideline M45-A2. CLSI, Wayne, PA, USA, 2010.
21. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
22. NARMS. NARMS 2009 Executive Report. 2009. http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm268951.htm (9 September [2011,] date last accessed).
23. Kahlmeter G, Brown DFJ. Resistance surveillance studies- comparability of results and quality assurance of methods. J Antimicrob Chemother 2002; 50: 775-7.
24. Schwartz S, Kehrenberg C, Walsh TR. Use of antimicrobial agents in veterinary medicine and food animal production. Int J Antimicrob Agents 2001; 17: 432-7.
25. Hakanen A, Kotilainen P, Huovinen P et al. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis 2001; 7: 996-1002.
26. Friederichs SM, de Jong A, Greife HA. Prevalence of antimicrobial resistance and detection of Qnr in avian Salmonellae in two EU regions, 1998-2006. Clin Microbiol Infect 2008; 14 Suppl 7: P2092.
27. de Jong A, Ludwig C, Stephan B. Twelve years of resistance monitoring of Salmonella from healthy chickens in two EU regions. Clin Microbiol Infect 2011; 17 Suppl S4: P1100.
28. Giraud E, Baucheron S, Cloeckaert A. Resistance to fluoroquinolones in Salmonella: emerging mechanisms and resistance prevention strategies. Microbes Infect 2006; 8: 1937-44.
29. O'Regan E, Quinn T, Frye JG et al. Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother 2010; 54: 367-74.
30. Bywater R, Silley P, Simjee S. Antimicrobial breakpoints-definitions and conflicting requirements. Vet Microbiol 2006; 118: 158-9.
31. Kahlmeter G, Brown DFJ, Goldstein FW et al. Harmonisation of MIC breakpoints for antimicrobial testing of bacteria. J Antimicrob Chemother 2003; 52: 145-8.
32. EFSA/ECDC. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in EFSA J 2011; 9: 2090.
33. Kist M. Impact and management of Campylobacter in human medicine-European perspective. Int J Infect Dis 2002; 6 Suppl 3: S44-8.
34. Wassenaar TM, Kist M, de Jong A. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents 2007; 30: 195-201.
35. Zhao S, Young SR, Tong E et al. Antimicrobial resistance of Campylobacter isolates from retail meat in the United States between 2002 and 2007. Appl Environ Microbiol 2010; 76: 7949-56.
36. NARMS. Retail Meat Report 2009. http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM257587.pdf (19 November 2011, date last accessed).
37. Murray BE. The life and times of the enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
38. Top J, Willems R, Bonten M. Emergence of CC17 Enterococcus faecium: from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 2008; 52: 297-308.
39. EFSA/ECDC. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in the European Union in 2009. EFSA J 2011; 9: 2154.
40. Simjee S, Silley P, Werling H-O et al. Potential confusion regarding the term 'resistance' in epidemiological surveys. J Antimicrob Chemother [2008;] 61: 228-9.
41. Belgian Veterinary Surveillance of Antimicrobial Consumption. National Consumption Report 2007-2008-2009. www.belvetsac.ugent.be (19 July 2011, date last accessed).
42. Sales of Antimicrobial Products Authorized for Use as Veterinary Medicines, Antiprotozoals, Antifungals and Coccidiostats in the UK in http://www.vmd.gov.uk/Publications/Antibiotic/salesanti09.pdf (4 October 2011, date last accessed).
43. European Surveillance of Veterinary Antimicrobial Consumption (ESVAC). Trends in the sales of veterinary antimicrobial agents in nine European countries. Reporting period: 2005-2009. EMA/238630/2011.
44. Grave K, Torren-Edo J, Mackay D. Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother 2010; 65: 2037-40.